OHM’s list and this link are a reminder of what we are aware of but will emerge in BP consciousness in stages…Leronlimab sits at the heart of inflammatory processes and immune regulation, an All Star player for HIV, cancer, NASH and all those html tag’s Respert noticed in OHM’s robust list. Maybe all these sit down coffee sessions with the FDA are really the byproduct of a new emerging relationship; maybe the FDA swiped right. Their functionaries can’t be presumed to be in any hurry, they are just doing their plodding beaurocratic job in Alfred E Neuman style: “What, me worry?”

It looks like nothing much is being accomplished but maybe a healthy working relationship is unfolding.

https://time.com/6269070/inflammation-deadly-diseases/